A systematic review of evidence-based treatment for individuals with treatment-resistant schizophrenia and a suboptimal response to clozapine monotherapy

Iyoni Ranasinghe and Jacqueline Sin

Psychosis, 2014, vol. 6, issue 3, 253-265

Abstract: Background: Currently, only clozapine is licensed for ‘treatment-resistant schizophrenia’ (TRS). However, ad hoc clozapine augmentation strategies are frequently resorted to, without clear guideline from evidence-based medicine, for individuals with a suboptimal response to clozapine monotherapy.Aims: To identify the optimal evidence-based clozapine augmentation regime with either pharmacological or psychosocial interventions, or a combination of pharmacological and psychosocial approaches.Method: Systematic analysis of randomised controlled trials of clozapine monotherapy versus clozapine/adjunctive medication and clozapine/psychosocial adjunctive therapiesResults: No trial was identified investigating clozapine augmentation with both psychosocial and pharmacological strategies. Six trials investigating clozapine augmentation with various medication, such as Lamotrigine, Risperidone, Aripiprazole and Sulpiride, were identified. These trials reported some effects on overall symptoms. Two trials of clozaoine augmentation with Cognitive Behavioural Therapy found positive effects on overall mental state and discussed an improved quality of life. One trial on Occupational Therapy-clozapine augmentation reported improved occupational performance and interpersonal relationships.Conclusion: Our review findings suggest psychosocial intervention augmentations are potentially effective treatments for service users with TRS. Less conclusive results are identified from the many pharmacological augmentation strategies. Longer and larger trials are required to demonstrate long-term effects.Declaration of Interest: None

Date: 2014
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
http://hdl.handle.net/10.1080/17522439.2013.830319 (text/html)
Access to full text is restricted to subscribers.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:taf:rpsyxx:v:6:y:2014:i:3:p:253-265

Ordering information: This journal article can be ordered from
http://www.tandfonline.com/pricing/journal/RPSY20

DOI: 10.1080/17522439.2013.830319

Access Statistics for this article

Psychosis is currently edited by Dr John Read

More articles in Psychosis from Taylor & Francis Journals
Bibliographic data for series maintained by Chris Longhurst ().